# ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

> **NCT01608061** · NA · COMPLETED · sponsor: **Functional Neuromodulation Ltd** · enrollment: 42 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** DBS-f on
- **DEVICE:** DBS-f off

## Key facts

- **NCT ID:** NCT01608061
- **Lead sponsor:** Functional Neuromodulation Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-06
- **Final completion:** 2018-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608061, "ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01608061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*